July 11, 2014 9:18 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Analysts at JP Morgan initiated coverage on Halozyme Therapeutics (NASDAQ: HALO) with a Outperform rating. The target price for Halozyme Therapeutics is set to $13. Halozyme Therapeutics' shares closed at $9.29 yesterday. Cowen & Company initiated coverage on shares of Lorillard (NYSE: LO) with an Underperform rating. The target price for Lorillard is set to $57. Lorillard's shares closed at $63.09 yesterday. Analysts at Oppenheimer initiated coverage on shares of Prothena (NASDAQ: PRTA) with a Outperform rating. The target price for Prothena is set to $40. Prothena's shares closed at $20.94 yesterday.Jefferies initiated coverage on shares of Sterling Bancorp (NYSE: STL) with a Buy rating. The target price for Sterling Bancorp is set to $14. Sterling Bancorp's shares closed at $12.11 yesterday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.